Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Your look at what's coming in the week starting March 2....
Snow blanketed a quiet New York village as lawmakers carried out a step many historians say had never happened before....
The Hezbollah leader of a Lebanese parliamentary bloc was killed on Sunday in air strikes conducted by the IDF....
